Search

Your search keyword '"Bologna, Katja"' showing total 10 results
Start Over Author "Bologna, Katja"
10 results on '"Bologna, Katja"'

1. Effect of dulaglutide in promoting abstinence during smoking cessation: 12-month follow-up of a single-centre, randomised, double-blind, placebo-controlled, parallel group trial

Author

Lüthi, Hualin, Lengsfeld, Sophia, Burkard, Thilo, Meienberg, Andrea, Jeanloz, Nica, Vukajlovic, Tanja, Bologna, Katja, Steinmetz, Michelle, Bathelt, Cemile, Sailer, Clara O., Laager, Mirjam, Vogt, Deborah R., Hemkens, Lars G., Speich, Benjamin, Urwyler, Sandrine A., Kühne, Jill, Baur, Fabienne, Lutz, Linda N., Erlanger, Tobias E., Christ-Crain, Mirjam, and Winzeler, Bettina

Published
2024
Full Text
View/download PDF

2. Effect of dulaglutide in promoting abstinence during smoking cessation: a single-centre, randomized, double-blind, placebo-controlled, parallel group trial

Author

Lengsfeld, Sophia, Burkard, Thilo, Meienberg, Andrea, Jeanloz, Nica, Vukajlovic, Tanja, Bologna, Katja, Steinmetz, Michelle, Bathelt, Cemile, Sailer, Clara O., Vogt, Deborah R., Hemkens, Lars G., Speich, Benjamin, Urwyler, Sandrine A., Kühne, Jill, Baur, Fabienne, Lutz, Linda N., Erlanger, Tobias E., Christ-Crain, Mirjam, and Winzeler, Bettina

Published
2023
Full Text
View/download PDF

3. BLOOD PRESSURE CHANGES DURING SMOKING CESSATION ON DULAGLUTIDE AND PLACEBO TREATMENT – A SECONDARY ANALYSIS OF THE RANDOMIZED, DOUBLE-BLIND, PLACEBO- CONTROLLED SKIP TRIAL

Author

Beck, Julia, primary, Hasenböhler, Flavia, additional, Lengsfeld, Sophia, additional, Burkard, Thilo, additional, Meienberg, Andrea, additional, Jeanloz, Nica, additional, Vukajlovic, Tanja, additional, Bologna, Katja, additional, Bathelt, Cemile, additional, Vogt, Deborah, additional, Werlen, Laura, additional, Christ-crain, Mirjam, additional, and Winzeler, Bettina, additional

Published
2024
Full Text
View/download PDF

4. Effect of a 1-year physical activity intervention on quality of life, fatigue, and distress in adult childhood cancer survivors-A randomized controlled trial (SURfit)

Author

Deng, Wei H; https://orcid.org/0000-0001-8194-9303, Zürcher, Simeon J; https://orcid.org/0000-0002-7759-747X, Schindera, Christina; https://orcid.org/0000-0002-4511-287X, Jung, Ruedi; https://orcid.org/0000-0001-9135-1495, Hebestreit, Helge; https://orcid.org/0000-0002-9266-7149, Bänteli, Iris, Bologna, Katja; https://orcid.org/0000-0002-1251-5373, von der Weid, Nicolas X; https://orcid.org/0000-0002-9555-3817, Kriemler, Susi; https://orcid.org/0000-0002-3384-7940, Rueegg, Corina S; https://orcid.org/0000-0003-3720-4659, Deng, Wei H; https://orcid.org/0000-0001-8194-9303, Zürcher, Simeon J; https://orcid.org/0000-0002-7759-747X, Schindera, Christina; https://orcid.org/0000-0002-4511-287X, Jung, Ruedi; https://orcid.org/0000-0001-9135-1495, Hebestreit, Helge; https://orcid.org/0000-0002-9266-7149, Bänteli, Iris, Bologna, Katja; https://orcid.org/0000-0002-1251-5373, von der Weid, Nicolas X; https://orcid.org/0000-0002-9555-3817, Kriemler, Susi; https://orcid.org/0000-0002-3384-7940, and Rueegg, Corina S; https://orcid.org/0000-0003-3720-4659

Abstract

INTRODUCTION Childhood cancer survivors (CCS) are at risk of experiencing lower quality-of-life, fatigue, and depression. Few randomized controlled trials have studied the effect of physical activity (PA) on these in adult long-term CCS. This study investigated the effect of a 1-year individualized PA intervention on health-related quality-of-life (HRQOL), fatigue, and distress symptoms in adult CCS. METHODS The SURfit trial randomized 151 CCS ≥16 years old, <16 at diagnosis and ≥5 years since diagnosis, identified through the Swiss Childhood Cancer Registry. Intervention participants received personalized PA counselling to increase intense PA by ≥2.5 h/week for 1 year. Controls maintained usual PA levels. The authors assessed physical- and mental-HRQOL, fatigue, and distress symptoms at baseline, 3, 6, and 12 months. T-scores were calculated using representative normative populations (mean = 50, standard deviation = 10). Generalized linear mixed-effects models with intention-to-treat (ITT, primary), and three per-protocol allocations were used. RESULTS At 12 months, ITT (-3.56 larger decrease, 95% confidence interval -5.69 to -1.43, p = .001) and two per-protocol analyses found significantly lower fatigue. Physical-HRQOL improved significantly in two per-protocol analyses at 12 months. No other effects were found. CONCLUSION SURfit showed that increased intense PA over 1 year improved fatigue in adult CCS. Survivors should be recommended PA to reduce the burden of late-effects.

Published
2024

5. Effect of a 1‐year physical activity intervention on quality of life, fatigue, and distress in adult childhood cancer survivors—A randomized controlled trial (SURfit)

Author

Deng, Wei H., primary, Zürcher, Simeon J., additional, Schindera, Christina, additional, Jung, Ruedi, additional, Hebestreit, Helge, additional, Bänteli, Iris, additional, Bologna, Katja, additional, von der Weid, Nicolas X., additional, Kriemler, Susi, additional, and Rueegg, Corina S., additional

Published
2024
Full Text
View/download PDF

6. RF32 | PSUN59 Glucagon-Like Peptide-1 Analogues: A New Way to Quit Smoking? SKIP – a Randomised Controlled Study

Author

Atila, Cihan, primary, Burkard, Thilo, additional, Meienberg, Andrea, additional, Jeanloz, Nica, additional, Vukajlovic, Tanja, additional, Bologna, Katja, additional, Steinmetz, Michelle, additional, Sailer, Clara, additional, Coynel, David, additional, Vogt, Deborah R, additional, Hemkens, Lars G, additional, Speich, Benjamin, additional, Kühne, Jill, additional, Baur, Fabienne, additional, Lutz, Linda, additional, Davide, Zanchi, additional, Christ-Crain, Mirjam, additional, Winzeler, Bettina, additional, and Lengsfeld, Sophia, additional

Published
2022
Full Text
View/download PDF

7. Glucagon-like peptide-1 analogues: a new way to quit smoking? SKIP - a randomised controlled study

Author

Lengsfeld, Sophia, primary, Burkard, Thilo, additional, Meienberg, Andrea, additional, Jeanloz, Nica, additional, Vukajlovic, Tanja, additional, Bologna, Katja, additional, Steinmetz, Michelle, additional, Sailer, Clara, additional, Coynel, David, additional, Vogt, Deborah R, additional, Hemkens, Lars G., additional, Speich, Benjamin, additional, Kuhne, Jill, additional, Baur, Fabienne, additional, Lutz, Linda, additional, Bathelt, Cemile, additional, Zanchi, Davide, additional, Christ-Crain, Mirjam, additional, and Winzeler, Bettina, additional

Published
2022
Full Text
View/download PDF

10. Effects of alcohol consumption on copeptin levels and sodium-water homeostasis.

Author

Sailer, Clara Odilia, Refardt, Julie, Bissig, Sarah, Bologna, Katja, Imber, Cornelia, and Christ-Crain, Mirjam

Abstract

Alcohol consumption influences sodium-water homeostasis. However, the effect of alcohol on vasopressin levels is controversial. The aim of the present study was to evaluate physiological changes of alcohol consumption on the stable vasopressin surrogate marker copeptin. In addition, we aimed at investigating the effect of additional sodium and/or water consumption on plasma sodium, osmolality, and copeptin levels. Ten healthy men underwent four interventions in random order: 1) beer consumption only, 2) beer consumption with additional water, 3) beer consumption with additional stock, or 4) water consumption only. Fluid consumption was equal between interventions and calculated to reach a blood alcohol concentration of 0.8‰ in the beer interventions. Blood and urinary samples were taken at six time points over the observation period of 720 min. The primary end point was the mean difference in copeptin levels 90 min after the start of fluid consumption, which showed no in-between group differences (P = 0.4). However, a higher total urinary volume excretion in all alcohol compared with water interventions was observed (P = 0.01). Furthermore, plasma copeptin, sodium, and urinary osmolality levels increased significantly at the end of the observation period in all alcohol compared with water-only interventions (P = 0.02). In conclusion, initial copeptin suppression does not differ between alcohol or water interventions but seems to be prolonged in the alcohol interventions. This leads to increased volume loss followed by a counterregulation with increased copeptin levels and water retention after 720 min in alcohol compared with interventions. Additional sodium and/or water consumption with alcohol did not change the observed alcohol-induced effects. [ABSTRACT FROM AUTHOR]

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results